Acute myeloid leukemia, also known as AML, is an aggressive cancer that attacks the bone marrow.
Around 30,000 people in the U.S. are diagnosed with it each year.
It’s the most common type of leukemia in older adults yet continues to have the lowest survival rates.
In Healthy Living, see how a new drug combination is stopping it in its tracks.
The CU Cancer Hematology Teams believe this new approach to killing cancer could destroy other tumor types including breast, pancreatic and colon.
There are two clinical trials enrolling patients right now, including the very first one for younger AML patients.
For more call 720-848-6400 or .
© 2023 - 910 Media Group